Skeletal injury is a leading cause of chronic pain and long-term disability worldwide. While most acute skeletal pain can be effectively managed with nonsteroidal anti-inflammatory drugs and opiates, chronic skeletal pain is more difficult to control using these same therapy regimens. One possibility as to why chronic skeletal pain is more difficult to manage over time is that there may be nerve sprouting in nonhealed areas of the skeleton that normally receive little (mineralized bone) to no (articular cartilage) innervation. If such ectopic sprouting did occur, it could result in normally nonnoxious loading of the skeleton being perceived as noxious and/or the generation of a neuropathic pain state. To explore this possibility, a mouse model of skeletal pain was generated by inducing a closed fracture of the femur. Examined animals had comminuted fractures and did not fully heal even at 90+ days post fracture. In all mice with nonhealed fractures, exuberant sensory and sympathetic nerve sprouting, an increase in the density of nerve fibers, and the formation of neuroma-like structures near the fracture site were observed. Additionally, all of these animals exhibited significant pain behaviors upon palpation of the nonhealed fracture site. In contrast, sprouting of sensory and sympathetic nerve fibers or significant palpation-induced pain behaviors was never observed in naïve animals. Understanding what drives this ectopic nerve sprouting and the role it plays in skeletal pain may allow a better understanding and treatment of this currently difficult-to-control pain state. Ó
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Introduction
Chronic skeletal diseases are prevalent and their impact on global health and disability is pervasive in both the developing and developed world. Importantly, if skeletal pain is not adequately controlled, it frequently has secondary effects, including the loss of mobility, bone and muscle mass, cardiovascular function, and cognitive health, all of which can significantly diminish the patient's functional status and quality of life [12, 46, 73, 99] .
In general, the incidence of skeletal pain tends to increase with age. In large part, this is because the mass, quality, and strength of the human skeleton peaks at 25-30 years of age, in both males and females, and then declines thereafter [30, 70] . Currently, the average lifespan of humans in both the developing and developed world is increasing to >80 years in several countries. Thus, the burden that skeletal pain will exact on individuals and society is expected to increase markedly in the coming decades [78, 91] . Additionally, lifestyle influences such as rising obesity rates and reduction in daily physical activity also reduce skeletal health.
One major reason chronic skeletal pain is frequently debilitating is that we currently have very few therapies that can attenuate this pain without significant, unwanted side effects. While both nonsteroidal anti-inflammatory drugs (NSAIDs) and opiates have been shown to be effective in attenuating acute skeletal pain, long-term use of these agents for managing chronic nonmalignant skeletal pain is problematic [17, 31] . Long-term NSAID use can induce significant renal, liver, and gastrointestinal toxicity and has also been suggested to inhibit bone healing [7, 9] 
